Expanding the potential therapeutic options of hemoperfusion in the era of improved sorbent biocompatibility.

Details

Serval ID
serval:BIB_0C698F05D5BB
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Expanding the potential therapeutic options of hemoperfusion in the era of improved sorbent biocompatibility.
Journal
Kidney research and clinical practice
Author(s)
Damianaki A., Stambolliu E., Alexakou Z., Petras D.
ISSN
2211-9132 (Print)
ISSN-L
2211-9132
Publication state
Published
Issued date
05/2023
Peer-reviewed
Oui
Volume
42
Number
3
Pages
298-311
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
Hemoperfusion has been considered a promising adjuvant treatment for chronic diseases and some acute states when specific removal of pathogenic factors from the bloodstream is desired. Over the years, advances in adsorption materials (e.g., new synthetic polymers, biomimetic coating, and matrixes with novel structures) have renewed scientific interest and expanded the potential therapeutic indications of hemoperfusion. There is growing evidence to suggest a prominent place for hemoperfusion as an adjuvant treatment in the setting of sepsis or severe coronavirus disease 2019 and as a therapeutic option for chronic complications associated with accumulated uremic toxins in patients with end-stage renal disease. This literature review will describe the principles, therapeutic perspectives, and the emerging role of hemoperfusion as a complementary therapy for patients with kidney disease.
Keywords
Adsorption, COVID-19, Hemodialysis, Hemoperfusion, Kidney diseases, Renal dialysis
Pubmed
Web of science
Open Access
Yes
Create date
01/05/2023 8:58
Last modification date
09/12/2023 8:02
Usage data